Pyoderma Gangrenosum

Also known as: Pyoderma gangrenous / Pyoderma gangenosum / Phagedenic pyoderma

DrugDrug NameDrug Description
DB00051AdalimumabA monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
DB00005EtanerceptA protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis.
DB00798GentamicinAn aminoglycoside used to treat a wide variety of infections in the body.
DB00864TacrolimusA calcineurin inhibitor used to prevent organ transplant rejection and to treat moderate to severe atopic dermatitis.
DrugDrug NamePhaseStatusCount
DB09029Secukinumab1 / 2Active Not Recruiting1
DB00051Adalimumab2Withdrawn2
DB06168Canakinumab2Completed1
DB14766Etrasimod2Terminated1
DB12119Gevokizumab2Completed1
DB11569Ixekizumab2Completed1
DB09029Secukinumab2Not Yet Recruiting1
DB00051Adalimumab3Completed1
DB12119Gevokizumab3Terminated3
DB00065InfliximabNot AvailableCompleted1